Hepatocyte Growth Factor and Cardiovascular Autonomic Function

In this study, we tested the hypothesis that elevated HGF is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients not receiving insulin treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type-2 Diabetes

Sex eligibility

All sexes

Study type

Observational

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Type-2 diabetes

Exclusion criteria

Type-1 diabetes

Sponsors and collaborators

Lead sponsor

Oita Red Cross Hospital

Other

Registry information

Important dates

First posted: May 24, 2007
Registry last updated: May 24, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed